Picture of Theravance Biopharma logo

TBPH — Theravance Biopharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Zymeworks strikes $929 million deal for Theravance Biopharma

Zymeworks strikes $929 million deal for Theravance Biopharma

- Drugmaker Zymeworks ZYME.O said on Monday it will buy Theravance Biopharma TBPH.O in a $929 million deal.


(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Jonathan Ananda)

((Padmanabhan.Ananthan@thomsonreuters.com;))

Recent news on Theravance Biopharma

See all news